UK markets closed

Sanofi (0A2V.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
49.56-0.51 (-1.02%)
At close: 07:00PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.42
52-week change 342.25%
S&P500 52-week change 323.76%
52-week high 357.78
52-week low 336.99
50-day moving average 353.46
200-day moving average 351.18

Share statistics

Avg vol (3-month) 320.42k
Avg vol (10-day) 3123.37k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 81.1B
% held by insiders 10.00%
% held by institutions 110.33%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 9.80%
Operating margin (ttm)18.28%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)46.29B
Revenue per share (ttm)18.49
Quarterly revenue growth (yoy)2.30%
Gross profit (ttm)N/A
EBITDA 12.2B
Net income avi to common (ttm)4.54B
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)-43.20%

Balance sheet

Total cash (mrq)8.71B
Total cash per share (mrq)6.98
Total debt (mrq)18.42B
Total debt/equity (mrq)24.78%
Current ratio (mrq)N/A
Book value per share (mrq)59.17

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A